UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 21, 2011
Accession Number:
Submission Type:
CIK:
0000949858
Company Name:
ONCOGENEX PHARMACEUTICALS, INC.
File Number:
333-177719